Triphase Accelerator (Marizomib Drug) is Buildings and Property in Canada that focus on oncology drug business. They cover business area such as portfolio, asset, marizomib, MRZ, an oncology drug, ownership, development, glioblastoma.
-
Oncology Drug
-
661 University Avenue
Suite 415
Toronto, Ontario M5G 1M1
Canada
Private
portfolioassetmarizomibMRZan oncology drugownershipdevelopmentglioblastoma
* We use standard office opening hours in near Triphase Accelerator (Marizomib Drug)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Triphase Accelerator (Marizomib Drug) is Buildings and Property business from Canada that founded in - ( years old in ), Triphase Accelerator (Marizomib Drug) business is focusing on Oncology Drug.
Triphase Accelerator (Marizomib Drug) headquarter office and corporate office address is located in 661 University Avenue Suite 415 Toronto, Ontario M5G 1M1 Canada.
Triphase Accelerator (Marizomib Drug) was founded in Canada.
In , Triphase Accelerator (Marizomib Drug) is currently focus on oncology drug sector.
Above is snippet of Google Trends for "oncology drug" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Triphase Accelerator (Marizomib Drug), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
